Patients with waldenström macroglobulinemia commonly present with iron deficiency and those with severely depressed transferrin saturation levels show response to parenteral iron administration

Clinical Lymphoma, Myeloma and Leukemia

Volumn 13, Issue 2, 2013, Pages 241-243

  Treon, Steven P ^a,b   Tripsas, Christina K ^a   Ciccarelli, Bryan T ^a   Manning, Robert J ^a   Patterson, Christopher J ^a   Sheehy, Patricia ^a   Hunter, Zachary R ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Anemia; Iron; Iron deficiency; Parenteral iron; Transferrin saturation; Waldenstr m macroglobulinemia

Indexed keywords

HEPCIDIN; IRON; TRANSFERRIN;

ANEMIA; CONFERENCE PAPER; FEMALE; FOLLOW UP; HEMATOCRIT; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; WALDENSTROEM MACROGLOBULINEMIA;

ANEMIA, IRON-DEFICIENCY; FEMALE; HUMANS; IRON; MALE; TRANSFERRIN; TREATMENT OUTCOME; WALDENSTROM MACROGLOBULINEMIA;

EID: 84877623953     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2013.02.016     Document Type: Conference Paper

References (19)

1. S.P. Treon How I treat Waldenström macroglobulinemia Blood 114 2009 2375 2385
2. R.E. Fleming, W.S. Sly Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease Proc Natl Acad Sci USA 98 2001 8160 8162 (Pubitemid 32678004)
3. C.H. Park, E.V. Valore, A.J. Waring Hepcidin, a urinary antimicrobial peptide synthesized in the liver J Biol Chem 276 2001 7806 7810
4. I. Theurl, M. Theurl, M. Seifert Autocrine formation of hepcidin induces iron retention in human monocytes Blood 111 2008 2392 2399 (Pubitemid 351451452)
5. J.P. Pinto, V. Dias, H. Zoller Hepcidin messenger RNA expression in human lymphocytes Immunology 130 2010 217 230
6. B.T. Ciccarelli, C.J. Patterson, Z.R. Hunter Hepcidin is produced by lymphoplasmacytic cells and is associated with anemia in Waldenström's macroglobulinemia Clin Lymphoma Myeloma Leuk 11 2011 160 163
7. E. Nemeth, M.S. Tuttle, J. Powelson Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization Science 306 2004 2090 2093 (Pubitemid 40007660)
8. I. De Domenico, D.M. Ward, C. Langelier The molecular mechanism of hepcidin-mediated ferroportin down-regulation Mol Biol Cell 18 2007 2569 2578 (Pubitemid 47025722)
9. I. De Domenico, E. Lo, D.M. Ward Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2 Proc Natl Acad Sci U S A 106 2009 3800 3805
10. G.E. Cartwright The anemia of chronic disorders Semin Hematol 3 1966 351 375
11. G. Birgegård Managing anemia in lymphoma and multiple myeloma Ther Clin Risk Manag 4 2008 527 539 (Pubitemid 351712012)
12. R.A. Kyle, S.P. Treon, R. Alexanian Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the second International workshop on Waldenstrom's macroglobulinemia Semin Oncol 30 2003 116 120 (Pubitemid 36506292)
13. R.G. Owen, S.P. Treon, A. Al-Katib Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia Semin Oncol 30 2003 110 115 (Pubitemid 36506291)
14. S. Sharma, E. Nemeth, Y.H. Chen Involvement of hepcidin in the anemia of multiple myeloma Clin Cancer Res 14 2008 3262 3267
15. K. Maes, E. Nemeth, G.D. Roodman In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2 Blood 116 2010 3635 3644
16. S. Hohaus, G. Massini, M. Giachelia Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin J Clin Oncol 28 2010 2538 2543
17. M. Auerbach, H. Ballard, J.R. Trout Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial J Clin Oncol 22 2004 1301 1307 (Pubitemid 41079845)
18. D.H. Henry, N.V. Dahl, M. Auerbach Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy Oncologist 12 2007 231 242
19. M. Hedenus, G. Birgegård, P. Näsman Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study Leukemia 21 2007 627 632 (Pubitemid 46444544)